Skip to content

Author

Mohammad Ahmadvand

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Clinical response rates and adverse events associated with therapeutic tumor vaccines in lymphoma: A systematic review.

OBJECTIVES This study aims to evaluate the therapeutic efficacy and safety of tumor vaccine therapy in patients suffering from Hodgkin (HL) and Non-Hodgkin Lymphoma (NHL). METHODS a systematic search was done in PUBMED, WOS, Embase and Scopus in order to identify relevant studies from their inception to February 8th,...

A. Ghasemi, Mohammadreza Ghasemi, Mohammadreza Heidari et al. · 0 citations
Review Sep 2026

Beyond the Generic Tumor: Engineering Patient-Specific Immune Ecosystems for Cancer.

Current evidence supports personalized immunotherapy as a promising approach for improving the precision of cancer treatment, but its clinical application remains constrained by biological, technical, manufacturing, regulatory, and clinical challenges.

Samira Anvari, Jalal Naghinezhad, Reza Farokhi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.